Health Condition 1: O- Medical and Surgical Health Condition 2: T451- Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
Conditions
Interventions
Intervention1: Individualised Homoeopathic medicine: Individualised Homoeopathic medicine in centesimal potency
Dose: Depending on the laws of susceptibility, it will be Individualized dosage (from s
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed Diagnosis of Cancer: Patients must have histologically confirmed malignancy and have undergone modern oncology treatment such as chemotherapy or radiotherapy. Experienced Side Effects: Patients should have documented mucositis, nausea, and/or vomiting attributable to cancer treatment (not due to unrelated causes or concurrent illnesses).
Exclusion criteria
Exclusion criteria: Age Below 18yrs of age and above 77 yrs Pregnancy and Breast feeding women Neutropenia less than 500 or more than WBC above 25000 Patient should be compliant with the medicine for atleast 6 doses or 2 days which ever is lesser
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To comparing the efficacy of indicated homoeopathic remedy in Centicimal Vs LM potency in reducing the severity of post oncology treatment adverse effects assessed by OMAS SCALE AND CTC scale. Reduction in severity and duration of mucositis as graded by established clinical scales (e.g., WHO Grading Scale for oral mucositis). Measured by standardized scales, such as the World Health Organization (WHO) Oral Toxicity Scale or the Oral Mucositis Assessment Scale (OMAS). Reduction in treatment interruptions or delays due to severity of symptoms. Improvement in nausea and vomiting frequency and intensity, often measured by Common Toxicity Criteria (CTC) or patient diaries.Timepoint: Baseline to every 15 days to end of study at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the time reduced for the meaningful improvement Hospital visits ? How much and reason for hospitalisation.Timepoint: Baseline to every 15 days to end of study at 3 months;Time until complete resolution of complaints. Compare severity and incidence of adverse events.Timepoint: Baseline to every 15 days to end of study at 3 months;Changes in the weight parameters amongst the enrolled patients.Timepoint: Baseline to every 15 days to end of study at 3 months | — |
Countries
India
Contacts
Public ContactDr Dharmendra Sharma
Dr.D.Y.Patil Homoeopathic medical college and research centre,
Outcome results
None listed